Schedule dependency of Idarubicin (Ida) and doxorubicin (Dox) toxicity
was investigated in vitro using the K562 human leukemia cell line. Fo
r Dox, repeated exposure to the IC30 (d x 3) resulted in comparable su
rvival as single exposure to the total accumulative dose (20%). For Id
a, repeated exposure to the IC30 (d x 3) decreased survival to 5%, whi
le single exposure to the total accumulative dose reduced survival onl
y to 20%. Total cellular accumulation of Dox was independent of schedu
le of exposure, while for Ida, repeated exposure resulted in a signifi
cantly higher drug accumulation compared to the single exposure to the
accumulative dose. The data indicate that the schedule-dependent diff
erences in cytotoxicity for the two compounds can be accounted for alm
ost exclusively by an increased cellular uptake and retention of Ida w
ith repeated drug exposure.